BZAM Ltd. BZAMF BZAM has agreed to purchased an aggregate of 630,000 class A shares in the capital of BZAM Cannabis Corp., from certain minority shareholders of BCC pursuant to share purchase agreements entered into with each of the BCC shareholders. As consideration for the share purchase, the company will issue an aggregate of 255,000 common shares of the company to the BCC shareholders, at an average deemed issuance price of $0.225 per common share. Such common shares will be issued in reliance on certain prospectus exemptions available under securities legislation and will be subject to a four-month plus one day statutory hold period.

The issuance of such common shares for the purpose of the share purchase remains subject to all necessary regulatory approvals including final acceptance by the Canadian Securities Exchange. Once approved, the closing of the share purchase will result in the company owning 71.2% of BCC, which is a 13.6% increase of the company's existing ownership stake of BCC.

Benzinga Cannabis Capital Conference

The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.

Photo: Benzinga edit with photos by cannabis signing document jarmoluk and lindsayfox on Pixabay

Related News

BZAM Sells Galaxie And Amends Credit Agreement

BZAM Q1 Revenue Grows 127.9% YoY, What About Profit?

BZAM's Medical Cannabis Products To Reach UK Market Via 4C LABS